EA005212B1
(ru)
|
1999-12-24 |
2004-12-30 |
Авентис Фарма Лимитед |
Азаиндолы
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
EP2335700A1
(en)
*
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
TWI329105B
(en)
*
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
GB0202679D0
(en)
*
|
2002-02-05 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
TW200307542A
(en)
|
2002-05-30 |
2003-12-16 |
Astrazeneca Ab |
Novel compounds
|
US7186716B2
(en)
|
2002-08-12 |
2007-03-06 |
Sugen, Inc. |
3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
|
SE0202463D0
(sv)
*
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
Novel compounds
|
US20050043212A1
(en)
*
|
2002-10-09 |
2005-02-24 |
Ford Kirschenbaum |
Differential inhibition of p38 map kinase isoforms
|
US20050288299A1
(en)
*
|
2002-10-09 |
2005-12-29 |
Mavunkel Babu J |
Azaindole derivatives as inhibitors of p38 kinase
|
AU2003279230A1
(en)
*
|
2002-10-09 |
2004-05-04 |
Scios Inc. |
AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE
|
US7098231B2
(en)
*
|
2003-01-22 |
2006-08-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US7223785B2
(en)
|
2003-01-22 |
2007-05-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
GB0305142D0
(en)
*
|
2003-03-06 |
2003-04-09 |
Eisai London Res Lab Ltd |
Synthesis
|
SE0301372D0
(sv)
*
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Novel compounds
|
US7226941B2
(en)
*
|
2003-06-30 |
2007-06-05 |
Hif Bio, Inc. |
Compound for treating angiogenesis
|
US7202363B2
(en)
|
2003-07-24 |
2007-04-10 |
Abbott Laboratories |
Thienopyridine and furopyridine kinase inhibitors
|
US8178671B2
(en)
|
2003-07-30 |
2012-05-15 |
Rigel Pharmaceuticals, Inc. |
Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
|
AU2004297235A1
(en)
|
2003-12-04 |
2005-06-23 |
Vertex Pharmaceuticals Incorporated |
Quinoxalines useful as inhibitors of protein kinases
|
WO2005061519A1
(en)
*
|
2003-12-19 |
2005-07-07 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
KR20120091276A
(ko)
*
|
2004-02-20 |
2012-08-17 |
베링거 인겔하임 인터내셔날 게엠베하 |
바이러스 폴리머라제 억제제
|
US7507826B2
(en)
*
|
2004-03-30 |
2009-03-24 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of JAK and other protein kinases
|
FR2868422B1
(fr)
*
|
2004-03-31 |
2006-07-14 |
Aventis Pharma Sa |
Nouveaux derives pyrrolo(2,3-b) pyridine, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
JP2007531744A
(ja)
*
|
2004-04-05 |
2007-11-08 |
武田薬品工業株式会社 |
6−アザインドール化合物
|
JP2007533753A
(ja)
*
|
2004-04-23 |
2007-11-22 |
タケダ サン ディエゴ インコーポレイテッド |
インドール誘導体及びキナーゼ阻害剤としてのその使用
|
MX2007001127A
(es)
*
|
2004-07-27 |
2007-07-11 |
Sgx Pharmaceuticals Inc |
Moduladores de pirrolo-piridina cinasa.
|
KR101257343B1
(ko)
*
|
2004-07-30 |
2013-04-23 |
메틸진 인코포레이티드 |
Vegf 수용체 및 hgf 수용체 신호전달 억제제
|
EP1797054A2
(en)
*
|
2004-08-02 |
2007-06-20 |
OSI Pharmaceuticals, Inc. |
Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
|
EP1778669A2
(en)
*
|
2004-08-18 |
2007-05-02 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
MX2007001986A
(es)
*
|
2004-08-26 |
2007-05-10 |
Pfizer |
Compuestos de aminoheteroarilo como inhibidores de proteina quinasa.
|
FR2876103B1
(fr)
*
|
2004-10-01 |
2008-02-22 |
Aventis Pharma Sa |
Nouveaux derives bis-azaindoles, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
US7713973B2
(en)
|
2004-10-15 |
2010-05-11 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
MY179032A
(en)
*
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
JP2008520745A
(ja)
|
2004-11-22 |
2008-06-19 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Rhoキナーゼの二環式阻害剤
|
US20090233955A1
(en)
*
|
2004-12-08 |
2009-09-17 |
Frazee James S |
1H-Pyrrolo[2,3-B]Pyridnes
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
JP2008521768A
(ja)
*
|
2004-12-23 |
2008-06-26 |
エフ.ホフマン−ラ ロシュ アーゲー |
ヘテロ環式カルバミン酸誘導体、それらの製造及び医薬品としての使用
|
EP1874769B1
(de)
|
2005-04-25 |
2011-09-14 |
Merck Patent GmbH |
Neuartige aza-heterozyklen als kinase-inhibitoren
|
FR2884821B1
(fr)
*
|
2005-04-26 |
2007-07-06 |
Aventis Pharma Sa |
Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
|
EP2354139A1
(en)
*
|
2005-05-20 |
2011-08-10 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyridines useful as inhibitors of protein kinase
|
CN101248080B
(zh)
|
2005-05-20 |
2012-09-05 |
梅特希尔基因公司 |
Vegf受体和hgf受体信号的抑制剂
|
JP5148499B2
(ja)
|
2005-05-20 |
2013-02-20 |
メチルジーン インコーポレイテッド |
Vegf受容体およびhgf受容体シグナル伝達の阻害剤
|
CA2607901C
(en)
|
2005-06-13 |
2016-08-16 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for treating degenerative bone disorders using a syk inhibitory 2,4-pyrimidinediamine
|
PT1734251E
(pt)
*
|
2005-06-17 |
2007-03-30 |
Magneti Marelli Powertrain Spa |
Injector de combustível
|
DK1893612T3
(da)
|
2005-06-22 |
2011-11-21 |
Plexxikon Inc |
Pyrrol [2,3-B]pyridin-derivater som proteinkinasehæmmere
|
KR101142363B1
(ko)
*
|
2005-06-27 |
2012-05-21 |
주식회사유한양행 |
피롤로피리딘 유도체를 포함하는 항암제 조성물
|
CA2618682C
(en)
*
|
2005-08-12 |
2011-06-21 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
WO2007044804A2
(en)
|
2005-10-11 |
2007-04-19 |
Chemocentryx, Inc. |
Piperidine derivatives and methods of use
|
US7371862B2
(en)
|
2005-11-11 |
2008-05-13 |
Pfizer Italia S.R.L. |
Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
CN101365700A
(zh)
|
2005-11-15 |
2009-02-11 |
沃泰克斯药物股份有限公司 |
可用作激酶抑制剂的氮杂吲唑
|
EP1963320A1
(en)
*
|
2005-12-07 |
2008-09-03 |
OSI Pharmaceuticals, Inc. |
Pyrrolopyridine kinase inhibiting compounds
|
LT2474545T
(lt)
|
2005-12-13 |
2017-02-27 |
Incyte Holdings Corporation |
Heteroarilu pakeisti pirolo[2,3-b]piridinai ir pirolo[2,3-b]pirimidinai kaip janus kinazės inhibitoriai
|
WO2007078335A2
(en)
*
|
2005-12-21 |
2007-07-12 |
Decode Genetics, Ehf. |
Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
|
BRPI0722364A2
(pt)
|
2006-01-17 |
2011-08-16 |
Vertex Pharma |
azaindóis, composição farmacêutica e usos dos referidos compostos
|
CN101466676B
(zh)
*
|
2006-04-12 |
2012-07-18 |
默沙东公司 |
吡啶基酰胺类t-型钙通道拮抗剂
|
ES2542344T3
(es)
*
|
2006-05-09 |
2015-08-04 |
Novaremed Ltd. |
Uso de inhibidores de tirosina cinasa Syk para el tratamiento de trastornos proliferativos celulares
|
EP2027087A2
(en)
*
|
2006-05-18 |
2009-02-25 |
MannKind Corporation |
Intracellular kinase inhibitors
|
GB0617161D0
(en)
*
|
2006-08-31 |
2006-10-11 |
Vernalis R&D Ltd |
Enzyme inhibitors
|
CL2007002617A1
(es)
*
|
2006-09-11 |
2008-05-16 |
Sanofi Aventis |
Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
|
SG158147A1
(en)
|
2006-10-09 |
2010-01-29 |
Takeda Pharmaceutical |
Kinase inhibitors
|
EP2223925A1
(en)
*
|
2006-10-09 |
2010-09-01 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
WO2008063888A2
(en)
|
2006-11-22 |
2008-05-29 |
Plexxikon, Inc. |
Compounds modulating c-fms and/or c-kit activity and uses therefor
|
PE20121126A1
(es)
*
|
2006-12-21 |
2012-08-24 |
Plexxikon Inc |
Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa
|
MX2009006700A
(es)
|
2006-12-21 |
2009-06-30 |
Vertex Pharma |
Derivados de 5-ciano-4-(pirolo)[2,3b]piridina-3-il)-pirimidinas utiles como inhibidores de proteina-cinasas.
|
AR064464A1
(es)
*
|
2006-12-22 |
2009-04-01 |
Genentech Inc |
Anticuerpos anti - receptor del factor de crecimiento insulinico
|
WO2008120818A1
(ja)
|
2007-03-29 |
2008-10-09 |
Asubio Pharma Co., Ltd. |
cPLA2阻害活性を有するインドール誘導体およびその用途並びに製造方法
|
LT3070090T
(lt)
|
2007-06-13 |
2019-06-25 |
Incyte Holdings Corporation |
Janus kinazės inhibitoriaus (r)-3-(4-(7h-pirol[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)-3-ciklopentilpropannitrilo druskų panaudojimas
|
WO2009012283A1
(en)
|
2007-07-17 |
2009-01-22 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
WO2009046448A1
(en)
|
2007-10-04 |
2009-04-09 |
Intellikine, Inc. |
Chemical entities and therapeutic uses thereof
|
JP5524071B2
(ja)
|
2007-10-24 |
2014-06-18 |
メルク・シャープ・アンド・ドーム・コーポレーション |
複素環フェニルアミドt型カルシウムチャネルアンタゴニスト
|
CA2702126A1
(en)
*
|
2007-10-24 |
2009-04-30 |
Merck Sharp & Dohme Corp. |
Heterocycle amide t-type calcium channel antagonists
|
PL2250172T3
(pl)
|
2008-02-25 |
2012-01-31 |
Hoffmann La Roche |
Pirolopirazynowe inhibitory kinazy
|
BRPI0907928A2
(pt)
|
2008-02-25 |
2015-07-28 |
Hoffmann La Roche |
Inibidores de pirrolopirazina quinase.
|
RU2503676C2
(ru)
|
2008-02-25 |
2014-01-10 |
Ф.Хоффманн-Ля Рош Аг |
Пирролопиразиновые ингибиторы киназы
|
ATE517107T1
(de)
*
|
2008-02-25 |
2011-08-15 |
Hoffmann La Roche |
Pyrrolopyrazinkinaseinhibitoren
|
ATE522534T1
(de)
|
2008-02-25 |
2011-09-15 |
Hoffmann La Roche |
Pyrrolopyrazin-kinasehemmer
|
NZ589336A
(en)
|
2008-03-05 |
2011-12-22 |
Methylgene Inc |
Pyridine derivatives as inhibitors of protein tyrosine kinase activity
|
JP5547099B2
(ja)
|
2008-03-14 |
2014-07-09 |
インテリカイン, エルエルシー |
キナーゼ阻害剤および使用方法
|
WO2009114874A2
(en)
|
2008-03-14 |
2009-09-17 |
Intellikine, Inc. |
Benzothiazole kinase inhibitors and methods of use
|
SI2300013T1
(en)
|
2008-05-21 |
2018-03-30 |
Adriad Pharmacaceuticals, Inc. |
Phosphorus derivatives as kinase inhibitors
|
US9273077B2
(en)
|
2008-05-21 |
2016-03-01 |
Ariad Pharmaceuticals, Inc. |
Phosphorus derivatives as kinase inhibitors
|
JP5767965B2
(ja)
*
|
2008-06-10 |
2015-08-26 |
プレキシコン インコーポレーテッドPlexxikon Inc. |
キナーゼを調節する5h−ピロロ[2,3−b]ピラジン誘導体、およびその適応症
|
CN102124009B
(zh)
|
2008-07-08 |
2014-07-23 |
因特利凯公司 |
激酶抑制剂及其使用方法
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
US8846664B2
(en)
|
2008-11-12 |
2014-09-30 |
Ariad Pharmaceuticals, Inc. |
Pyrazinopyrazines and derivatives as kinase inhibitors
|
BRPI0921392A2
(pt)
|
2008-12-05 |
2016-04-26 |
Abbott Lab |
inibidores quinase com perfil de segurança cyp aperfeiçoado
|
WO2010063634A1
(en)
*
|
2008-12-05 |
2010-06-10 |
F. Hoffmann-La Roche Ag |
Pyrrolopyrazinyl urea kinase inhibitors
|
WO2010068292A1
(en)
*
|
2008-12-12 |
2010-06-17 |
Ariad Pharmaceuticals, Inc. |
Azaindole derivatives as kinase inhibitors
|
KR101724293B1
(ko)
|
2009-02-25 |
2017-04-07 |
다케다 야쿠힌 고교 가부시키가이샤 |
피롤 화합물의 제조 방법
|
US20110112101A1
(en)
*
|
2009-03-05 |
2011-05-12 |
Sanofi-Aventis |
Treatment for ocular-related disorders
|
ES2552386T3
(es)
*
|
2009-04-03 |
2015-11-27 |
F. Hoffmann-La Roche Ag |
Composiciones de {3-[5-(4-cloro-fenil)-1H-pirrol[2,3-b]piridin-3-carbonil]-2,4-difluoro-fenil}-amida del ácido propano-1-sulfónico y usos de las mismas
|
WO2010135411A2
(en)
*
|
2009-05-19 |
2010-11-25 |
The Regents Of The University Of Colorado |
Aurora-a copy number and sensitivity to inhibitors
|
WO2010146059A2
(en)
|
2009-06-16 |
2010-12-23 |
F. Hoffmann-La Roche Ag |
Biomarkers for igf-1r inhibitor therapy
|
HUE031048T2
(en)
|
2009-06-17 |
2017-06-28 |
Vertex Pharma |
Influenza virus replication inhibitors
|
US8329724B2
(en)
|
2009-08-03 |
2012-12-11 |
Hoffmann-La Roche Inc. |
Process for the manufacture of pharmaceutically active compounds
|
FR2949467B1
(fr)
|
2009-09-03 |
2011-11-25 |
Sanofi Aventis |
Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
|
JP2013510166A
(ja)
|
2009-11-06 |
2013-03-21 |
プレキシコン インコーポレーテッド |
キナーゼ調節のための化合物、方法およびその適用
|
EP2338890A1
(en)
|
2009-12-22 |
2011-06-29 |
Bayer CropScience AG |
4,7-Diazaindole derivatives and their use as fungicides
|
GEP20156243B
(en)
|
2009-12-23 |
2015-02-10 |
Takeda Pharmaceutical |
Fused heteroaromatic pyrrolidinones as syk inhibitors
|
AU2011209649A1
(en)
*
|
2010-01-27 |
2012-08-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyrazine kinase inhibitors
|
WO2011109932A1
(en)
*
|
2010-03-09 |
2011-09-15 |
F.Hoffmann-La Roche Ag |
Novel process for the manufacture of 5-halogenated-7-azaindoles
|
AR081315A1
(es)
|
2010-03-10 |
2012-08-08 |
Incyte Corp |
Derivados heterociclicos de piperidin y pirimidin -4-il-azetidina, una forma cristalina de la sal del acido acetonitriladipico de un derivado pirimidinico, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades relacionadas con la inhibicion de jak-1, t
|
US8518945B2
(en)
|
2010-03-22 |
2013-08-27 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
US8481541B2
(en)
*
|
2010-03-22 |
2013-07-09 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
TWI496785B
(zh)
*
|
2010-05-20 |
2015-08-21 |
Hoffmann La Roche |
吡咯并吡激酶抑制劑
|
CN103003281A
(zh)
*
|
2010-05-20 |
2013-03-27 |
弗·哈夫曼-拉罗切有限公司 |
作为JAK和SYK抑制剂的吡咯并[2,3-b]吡嗪-7-甲酰胺衍生物和它们的用途
|
ME02445B
(me)
|
2010-05-21 |
2016-09-20 |
Incyte Holdings Corp |
Topikalna formulacija za inhibiciju jak-a
|
WO2011149950A2
(en)
*
|
2010-05-24 |
2011-12-01 |
University Of Rochester |
Bicyclic heteroaryl kinase inhibitors and methods of use
|
WO2011153049A1
(en)
|
2010-06-02 |
2011-12-08 |
The Trustees Of The University Of Pennsylvania |
Methods and use of compounds that bind to her2/neu receptor complex
|
WO2011153050A1
(en)
|
2010-06-02 |
2011-12-08 |
The Trustees Of The University Of Pennsylvania |
Methods and use of compounds that bind to her2/neu receptor complex
|
EP2635556B1
(en)
*
|
2010-11-01 |
2017-06-21 |
Portola Pharmaceuticals, Inc. |
Benzamides and nicotinamides as syk modulators
|
AR083933A1
(es)
|
2010-11-19 |
2013-04-10 |
Incyte Corp |
Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
|
CN103492381A
(zh)
|
2010-12-16 |
2014-01-01 |
沃泰克斯药物股份有限公司 |
流感病毒复制的抑制剂
|
US8754114B2
(en)
|
2010-12-22 |
2014-06-17 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
|
AU2012214762B2
(en)
|
2011-02-07 |
2015-08-13 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
TWI558702B
(zh)
|
2011-02-21 |
2016-11-21 |
普雷辛肯公司 |
醫藥活性物質的固態形式
|
CN106619647A
(zh)
|
2011-02-23 |
2017-05-10 |
因特利凯有限责任公司 |
激酶抑制剂的组合及其用途
|
EA201391626A1
(ru)
|
2011-05-04 |
2014-03-31 |
Ариад Фармасьютикалз, Инк. |
Соединения для ингибирования клеточной пролиферации в egfr-стимулированных типах рака
|
EP2706852B1
(en)
|
2011-05-10 |
2018-08-22 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as syk inhibitors
|
AU2012253885A1
(en)
|
2011-05-10 |
2013-10-31 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as Syk inhibitors
|
JP2014513687A
(ja)
|
2011-05-10 |
2014-06-05 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Syk阻害薬としてのピリジルアミノピリジン
|
PE20140832A1
(es)
|
2011-06-20 |
2014-07-14 |
Incyte Corp |
Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak
|
EP2723739B1
(en)
|
2011-06-22 |
2016-08-24 |
Takeda Pharmaceutical Company Limited |
Substituted 6-aza-isoindolin-1-one derivatives
|
MX2013015147A
(es)
|
2011-07-05 |
2014-03-27 |
Vertex Pharma |
Procesos y compuestos intermediarios para producir azaindoles.
|
US8436179B2
(en)
|
2011-07-20 |
2013-05-07 |
Abbvie Inc. |
Kinase inhibitor with improved solubility profile
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
DE102011111400A1
(de)
*
|
2011-08-23 |
2013-02-28 |
Merck Patent Gmbh |
Bicyclische heteroaromatische Verbindungen
|
HUE041576T2
(hu)
|
2011-09-14 |
2019-05-28 |
Samumed Llc |
Indazol-3-karboxamid-származékok és alkalmazásuk Wnt/b-katenin szignalizáló útvonal inhibitorokként
|
EP2763975B1
(en)
|
2011-10-05 |
2016-04-06 |
Merck Sharp & Dohme Corp. |
3-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
|
US9006444B2
(en)
|
2011-10-05 |
2015-04-14 |
Merck Sharp & Dohme Corp. |
Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
|
US9216173B2
(en)
|
2011-10-05 |
2015-12-22 |
Merck Sharp & Dohme Corp. |
2-Pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
CN104662018B
(zh)
|
2012-04-20 |
2017-10-24 |
阿迪维纳斯治疗有限公司 |
取代的杂双环化合物、组合物及其医疗应用
|
JP6469567B2
(ja)
|
2012-05-05 |
2019-02-13 |
アリアド・ファーマシューティカルズ・インコーポレイテッド |
Egfr発動性がんの細胞増殖阻害用化合物
|
US9150570B2
(en)
|
2012-05-31 |
2015-10-06 |
Plexxikon Inc. |
Synthesis of heterocyclic compounds
|
ME03300B
(me)
|
2012-06-13 |
2019-07-20 |
Incyte Holdings Corp |
Supsтituisana triciklična jedinjenja као inhibiтori fgfr
|
EP2863914B1
(en)
|
2012-06-20 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
Pyrazolyl derivatives as syk inhibitors
|
US9487504B2
(en)
|
2012-06-20 |
2016-11-08 |
Merck Sharp & Dohme Corp. |
Imidazolyl analogs as syk inhibitors
|
EP2863916B1
(en)
|
2012-06-22 |
2018-07-18 |
Merck Sharp & Dohme Corp. |
Substituted pyridine spleen tyrosine kinase (syk) inhibitors
|
EP2863915B1
(en)
|
2012-06-22 |
2017-12-06 |
Merck Sharp & Dohme Corp. |
SUBSTITUTED DIAZINE AND TRIAZINE SPLEEN TYROSINE KINASE (Syk) INHIBITORS
|
CN102718694B
(zh)
*
|
2012-06-27 |
2014-04-02 |
上海大学 |
3-氰基取代吲哚化合物及其合成方法
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
US9353066B2
(en)
|
2012-08-20 |
2016-05-31 |
Merck Sharp & Dohme Corp. |
Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors
|
CA3178452A1
(en)
|
2012-11-15 |
2014-05-22 |
Incyte Holdings Corporation |
Sustained-release dosage forms of ruxolitinib
|
EP2738172A1
(en)
*
|
2012-11-28 |
2014-06-04 |
Almirall, S.A. |
New bicyclic compounds as crac channel modulators
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
CA2897400A1
(en)
|
2013-01-08 |
2014-07-17 |
Samumed, Llc |
3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof
|
US9468681B2
(en)
|
2013-03-01 |
2016-10-18 |
California Institute Of Technology |
Targeted nanoparticles
|
LT3489239T
(lt)
|
2013-03-06 |
2022-03-10 |
Incyte Holdings Corporation |
Jak inhibitoriaus gamybos būdai ir tarpiniai junginiai
|
ME03564B
(me)
|
2013-03-13 |
2020-07-20 |
Forma Therapeutics Inc |
DERIVATI 2-HIDROKSI-1-{4-[(4-FENILFENIL)KARBONIL]PIPERAZIN-1-IL}ETAN-1-ONA l SRODNA JEDINJENJA KAO INHIBITORI SINTAZE MASNIH KISELINA (FASN) ZA LEČENJE KANCERA
|
TW201444836A
(zh)
*
|
2013-03-14 |
2014-12-01 |
Abbvie Inc |
吡咯并[2,3-b]吡啶cdk9激酶抑制劑
|
MX2015012899A
(es)
*
|
2013-03-14 |
2016-06-02 |
Abbvie Inc |
Pirrolo [2,3-b] piridina como inhibidores de quinasa cdk9.
|
US9611283B1
(en)
|
2013-04-10 |
2017-04-04 |
Ariad Pharmaceuticals, Inc. |
Methods for inhibiting cell proliferation in ALK-driven cancers
|
ES2657451T3
(es)
|
2013-04-19 |
2018-03-05 |
Incyte Holdings Corporation |
Heterocíclicos bicíclicos como inhibidores del FGFR
|
MY195091A
(en)
|
2013-08-07 |
2023-01-10 |
Incyte Corp |
Sustained Release Dosage Forms for a JAK1 Inhibitor
|
WO2015029447A1
(ja)
*
|
2013-08-30 |
2015-03-05 |
興和株式会社 |
光学活性カルビノール化合物の製造方法
|
CN105849100B
(zh)
|
2013-11-13 |
2019-07-16 |
沃泰克斯药物股份有限公司 |
流感病毒复制抑制剂
|
RS57541B1
(sr)
|
2013-11-13 |
2018-10-31 |
Vertex Pharma |
Postupci za pripremu inhibitora replikacije virusa gripa
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
BR112017012272A2
(pt)
*
|
2014-12-11 |
2018-01-30 |
Beta Pharma, Inc. |
derivados de 2-anilinopirimidina como moduladores de egfr
|
ES2751669T3
(es)
|
2015-02-20 |
2020-04-01 |
Incyte Corp |
Heterociclos bicíclicos como inhibidores FGFR
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
US9580423B2
(en)
|
2015-02-20 |
2017-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
JP6704416B2
(ja)
|
2015-05-13 |
2020-06-03 |
バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated |
インフルエンザウイルスの複製の阻害剤を調製する方法
|
WO2016183120A1
(en)
|
2015-05-13 |
2016-11-17 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
WO2017003668A1
(en)
|
2015-07-01 |
2017-01-05 |
California Institute Of Technology |
Cationic mucic acid polymer-based delivery systems
|
WO2017024015A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017023975A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
US10206909B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10604512B2
(en)
|
2015-08-03 |
2020-03-31 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
|
WO2017023984A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
WO2017023996A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
WO2017023988A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017024025A1
(en)
|
2015-08-03 |
2017-02-09 |
Sunil Kumar Kc |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10285982B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
WO2017023972A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017024003A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017024010A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
WO2017024021A1
(en)
*
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
US10166218B2
(en)
|
2015-08-03 |
2019-01-01 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
US10226448B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
|
WO2017023993A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10392383B2
(en)
|
2015-08-03 |
2019-08-27 |
Samumed, Llc |
3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
PL3362449T3
(pl)
*
|
2015-10-13 |
2021-12-13 |
Institut National De La Santé Et De La Recherche Médicale (Inserm) |
Pochodne sybiriliny do zastosowania do zapobiegania i/lub leczenia zaburzeń związanych z nekroptozą komórkową
|
CN108472290A
(zh)
|
2015-11-06 |
2018-08-31 |
萨穆梅德有限公司 |
治疗骨关节炎
|
KR20180086247A
(ko)
*
|
2015-12-07 |
2018-07-30 |
플렉시콘 인코퍼레이티드 |
키나제 조절을 위한 화합물 및 방법과 이들에 대한 징후
|
AR107030A1
(es)
*
|
2015-12-09 |
2018-03-14 |
Padlock Therapeutics Inc |
Inhibidores aza-bencimidazol de pad4
|
WO2017151409A1
(en)
|
2016-02-29 |
2017-09-08 |
University Of Florida Research Foundation, Incorporated |
Chemotherapeutic methods
|
CN106008306A
(zh)
*
|
2016-06-28 |
2016-10-12 |
山东大学 |
取代吲哚类衍生物及其制备方法与应用
|
MX2019004616A
(es)
|
2016-10-21 |
2019-11-21 |
Samumed Llc |
Métodos de uso de indazol-3-carboxamidas y su uso como inhibidores de la ruta de señalización de wnt/b-catenina.
|
WO2018085865A1
(en)
|
2016-11-07 |
2018-05-11 |
Samumed, Llc |
Single-dose, ready-to-use injectable formulations
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
US10428067B2
(en)
|
2017-06-07 |
2019-10-01 |
Plexxikon Inc. |
Compounds and methods for kinase modulation
|
US10596161B2
(en)
|
2017-12-08 |
2020-03-24 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
WO2019152374A1
(en)
|
2018-01-30 |
2019-08-08 |
Incyte Corporation |
Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
|
MX2020010322A
(es)
|
2018-03-30 |
2022-11-30 |
Incyte Corp |
Tratamiento de la hidradenitis supurativa mediante el uso de inhibidores de actividad de la cinasa janus (jak).
|
CN108358894B
(zh)
*
|
2018-04-26 |
2021-05-07 |
四川大学 |
一种抑制组蛋白乙酰转移酶的化合物及其制备方法与应用
|
CR20200590A
(es)
|
2018-05-04 |
2021-04-26 |
Incyte Corp |
Formas sólidas de un inhibidor de fgfr y procesos para prepararlas
|
JP2021523118A
(ja)
|
2018-05-04 |
2021-09-02 |
インサイト・コーポレイションIncyte Corporation |
Fgfr阻害剤の塩
|
TWI767148B
(zh)
|
2018-10-10 |
2022-06-11 |
美商弗瑪治療公司 |
抑制脂肪酸合成酶(fasn)
|
CN113382633A
(zh)
|
2018-10-29 |
2021-09-10 |
福马治疗股份有限公司 |
(4-(2-氟-4-(1-甲基-1H-苯并[d]咪唑-5-基)苯甲酰基)哌嗪-1-基)(1-羟基环丙基)甲酮的固体形式
|
CN113874015B
(zh)
|
2018-12-21 |
2024-05-24 |
细胞基因公司 |
Ripk2的噻吩并吡啶抑制剂
|
TW202043205A
(zh)
|
2018-12-31 |
2020-12-01 |
美商拜歐米富士恩有限公司 |
Menin-mll相互作用之抑制劑
|
SG11202106304RA
(en)
|
2018-12-31 |
2021-07-29 |
Biomea Fusion Llc |
Irreversible inhibitors of menin-mll interaction
|
WO2020160151A1
(en)
*
|
2019-01-31 |
2020-08-06 |
Kyorin Pharmaceutical Co., Ltd. |
15-pgdh inhibitors
|
US11628162B2
(en)
|
2019-03-08 |
2023-04-18 |
Incyte Corporation |
Methods of treating cancer with an FGFR inhibitor
|
CN111171001B
(zh)
*
|
2019-05-16 |
2022-04-29 |
百济神州(苏州)生物科技有限公司 |
一种parp抑制剂中间体的结晶方法
|
US11591329B2
(en)
|
2019-07-09 |
2023-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
IL291901A
(en)
|
2019-10-14 |
2022-06-01 |
Incyte Corp |
Bicyclyl heterocycles as fgr suppressors
|
US11566028B2
(en)
|
2019-10-16 |
2023-01-31 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
JP2023505257A
(ja)
|
2019-12-04 |
2023-02-08 |
インサイト・コーポレイション |
Fgfr阻害剤の誘導体
|
JP2023505258A
(ja)
|
2019-12-04 |
2023-02-08 |
インサイト・コーポレイション |
Fgfr阻害剤としての三環式複素環
|
JP2023512647A
(ja)
*
|
2020-01-30 |
2023-03-28 |
アニマ バイオテック インコーポレイテッド |
コラーゲン1翻訳阻害剤およびその使用方法
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
CA3220274A1
(en)
|
2021-06-09 |
2022-12-15 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
WO2024026500A2
(en)
*
|
2022-07-28 |
2024-02-01 |
University Of Maryland, Baltimore |
Inhibitors of pde11a4 and methods of using same
|